Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 6 · below the Ichimoku cloud · RSI 36 · MACD above its signal
| 4.17 | 52-week high | +544.61% |
| 1.09 | Previous month high | +68.50% |
| 0.9590 | Previous week high | +48.25% |
| 0.8980 | R3 (classic) | +38.82% |
| 0.8090 | R2 (classic) | +25.06% |
| 0.7280 | R1 (classic) | +12.54% |
| 0.7200 | Previous day high | +11.30% |
| 0.6469 | Price now | |
| 0.6390 | Pivot | −1.22% |
| 0.6250 | Previous month low | −3.39% |
| 0.5580 | S1 (classic) | −13.74% |
| 0.5500 | Previous day low | −14.98% |
| 0.5500 | Previous week low | −14.98% |
| 0.5500 | 52-week low | −14.98% |
| 0.4690 | S2 (classic) | −27.50% |
| 0.3880 | S3 (classic) | −40.02% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $123.1K | 0.00% | 82.62K | −28% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SNES trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 27, 2026 | Edell MichaelChief Executive Officer | Purchase at price 0.64 per share. | 2K | $1.29K |
| Sep 13, 2026 | Edell MichaelChief Executive Officer | Purchase at price 0.84 per share. | 1K | $840 |
| Sep 8, 2026 | Edell MichaelChief Executive Officer | Purchase at price 0.85 - 0.89 per share. | 2K | $1.74K |
| Aug 13, 2026 | Edell MichaelChief Executive Officer | Purchase at price 1.21 per share. | 1K | $1.21K |
| Aug 6, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.30 per share. | 21.5K | $27.86K |
| Jul 19, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.47 per share. | 35K | $51.57K |
| Jul 6, 2026 | Edell MichaelChief Executive Officer | Purchase at price 1.43 per share. | 1K | $1.43K |
| Jun 29, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.51 per share. | 35K | $52.73K |
| Jun 28, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.52 - 1.56 per share. | 25.4K | $39.10K |
| Jun 21, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.61 - 1.66 per share. | 8.3K | $13.56K |
| Jun 7, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.57 - 1.65 per share. | 28.4K | $45.54K |
| Jun 7, 2026 | Edell MichaelChief Executive Officer | Purchase at price 1.55 per share. | 1K | $1.55K |
| May 17, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.59 - 1.72 per share. | 32.1K | $53.49K |
| May 14, 2026 | Edell MichaelChief Executive Officer | Purchase at price 1.62 - 1.70 per share. | 3K | $5.01K |
| Apr 27, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.47 per share. | 3K | $4.41K |
| Mar 16, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.79 - 1.95 per share. | 171K | $330.18K |
| Feb 18, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 2.29 - 2.40 per share. | 85.9K | $200.63K |
| Feb 12, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.72 - 1.89 per share. | 31.3K | $56.67K |
| Feb 4, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.77 - 1.82 per share. | 8.6K | $15.48K |
| Feb 1, 2026 | Glenbrook Capital ManagementBeneficial Owner of more than 10% of a Class of Security | Purchase at price 1.87 - 1.98 per share. | 48.1K | $94.52K |
TimeframesDown on all 4 timeframes: no timeframe is holding up.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.6 | 21.6 | -27.1 | -13.4 | 21.8 | -13.9 | -9.4 | -21.5 | -36.1 | -4.4 | −69.8% | ||
| 2025 | -14.5 | 2.5 | -37.6 | 24.3 | 23.1 | 83.8 | 2.9 | -5.7 | -11.1 | -24.4 | -12.3 | -26.5 | −35.3% |
| 2024 | -38.2 | 14.6 | -24.1 | 11.3 | -1.4 | -23.1 | -20.1 | -31.6 | -18.1 | 8.5 | -19.6 | 47.1 | −73.9% |
| 2023 | 23.9 | -44.9 | -29.4 | -20.8 | 0.0 | -5.1 | -17.0 | -37.8 | -27.3 | -28.6 | -73.3 | 32.3 | −96.6% |
| 2022 | -3.0 | -19.5 | -4.6 | -6.4 | -27.4 | 6.3 | 2.1 | 4.1 | -37.3 | -50.4 | -16.7 | 6.6 | −84.2% |
| 2021 | 3.2 | 0.6 | -7.3 | -6.0 | 3.8 | -0.6 | -5.6 | 13.8 | -12.7 | -2.6 | -15.6 | -21.0 | −43.2% |
| 2020 | -36.2 | -52.7 | -37.7 | 3.9 | -11.2 | 4.7 | -10.0 | -20.6 | 31.5 | -25.0 | 14.2 | 7.1 | −84.3% |
| 2019 | 33.3 | 17.3 | 33.3 | 37.7 | -10.1 | 19.2 | -13.9 | -30.3 | -6.5 | -28.8 | -13.8 | -11.3 | −6.0% |
| 2018 | -2.1 | -15.0 | -14.9 | -11.8 | 197.8 | 21.6 | -27.0 | -26.1 | -21.6 | 14.5 | -18.0 | -9.7 | −18.8% |
| 2017 | -5.0 | 4.8 | -2.5 | -9.6 | -14.7 | -6.6 | -39.8 | -33.2 | -19.2 | 44.9 | -67.0 | -18.6 | −91.2% |
| 2016 | — |
Buy / hold / sell counts
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.